ISOLATED SEPTAL CARTILAGE EXOSOME USED FOR GENERATING CARTILAGE TISSUE

A cartilage is generated by a formulation, wherein the formulation is produced by an isolated septal cartilage exosome released by cells isolated from a septal cartilage to a medium. The objective of the isolated septal cartilage exosome is to generate the cartilage to be used in a treatment of cart...

Full description

Saved in:
Bibliographic Details
Main Authors TA LI, Pakize Neslihan, APD K, Hüseyin, AH N, Fikrettin, AV AR APD K, Ezgi, AFAK, Ay e Sezim
Format Patent
LanguageEnglish
French
German
Published 28.07.2021
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:A cartilage is generated by a formulation, wherein the formulation is produced by an isolated septal cartilage exosome released by cells isolated from a septal cartilage to a medium. The objective of the isolated septal cartilage exosome is to generate the cartilage to be used in a treatment of cartilage tissue defects, such as osteoarthritis or arthrosis, since the cartilage induces a cartilage formation and also suppresses an inflammatory response.
Bibliography:Application Number: EP20190861961